Roivant Sciences ROIV
NASDAQ ROIV
$34.94 +0.53 (+1.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Roivant Sciences (ROIV) Interest Coverage Ratio (2022 - 2024)

Roivant Sciences' (ROIV) quarterly Interest Coverage Ratio came in at 4639.89 in Q3 2025, down 156050.86% YoY from N/an in Q3 2024, and down 199.64% on a QoQ basis from 1548.49 in Q2 2025.

Analysis

Roivant Sciences (ROIV) Interest Coverage Ratio (2022 - 2024) Analysis & Trends

Roivant Sciences (ROIV) has 6 years of Interest Coverage Ratio data on file, last reported at 4639.89 in Q3 2025.

  • Quarterly Interest Coverage Ratio fell 156050.86% year-over-year to 4639.89 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 25018.14 (down 64469.86% YoY) and the FY2026 annual result came in at 0.32, up 77.46% from the prior year.
  • Interest Coverage Ratio fell to 4639.89 in Q3 2025, from 1548.49 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 185.76 in Q4 2023 to a low of 4639.89 in Q3 2025.
  • A 5-year average of 462.14 and a median of 26.86 in 2022 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 482.76% — and 2025, when it slumped 156050.86%.
  • Tracing ROIV's Interest Coverage Ratio over 5 years: stood at 194.9 in 2021, then jumped by 75.1% to 48.53 in 2022, then jumped by 482.76% to 185.76 in 2023, then slumped by 103.42% to 6.35 in 2024, then tumbled by 73019.14% to 4639.89 in 2025.
  • The last three Interest Coverage Ratio figures came in at 4639.89 (Q3 2025), 1548.49 (Q2 2025), and 6.35 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Roivant Sciences 25.18 Bn 25.18 Bn 1.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -7.63
Dec 31, 2023 185.76
Sep 30, 2023 -23.13
Jun 30, 2023 -31.02
Dec 31, 2022 -48.53
Sep 30, 2022 -33.69
Jun 30, 2022 -108.08